Skip to main content

Table 3 Results of association between CTCs and clinicopathological characteristics

From: Prognostic value of circulating tumor cells detected with the CellSearch system in esophageal cancer patients: a systematic review and meta-analysis

 

OR (95% CI)

N

P-value

Age: > 65 vs. ≤65(OR)

1.07 (0.62,1.87) I2 = 0%

4

0.8

Sex: male vs. female (OR)

1.01 (0.53,1.91) I2 = 0%

5

0.98

Histology: AC vs. SCC

1.86 (0.81,4.26) I2 = 0%

4

0.14

pT: T3/T4 vs. T1/T2(OR)

2.92 (1.31,6.51) I2 = 0%

3

0.009

LN3 vs. LN [2](OR)

1.06 (0.61,1.86) I2 = 0%

4

0.83

pM:M1 vs. M0(OR)

5.18 (2.38,11.25) I2 = 0%

4

< 0.001

Stage: III/IV vs. I/II (OR)

1.36 (0.68,2.71) I2 = 0%

3

0.38

  1. OR Odds ratio
  2. P-value for estimates of OR
  3. “-”: not available
  4. LN Lymph node
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us